Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CNY 4.77
(0.0%)
CNY 4.77
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.89 Billion CNY | 10.66% |
| 2022 | 3.55 Billion CNY | -10.18% |
| 2021 | 3.96 Billion CNY | 2.45% |
| 2020 | 3.86 Billion CNY | -23.58% |
| 2019 | 5.05 Billion CNY | -3.33% |
| 2018 | 5.23 Billion CNY | 36.11% |
| 2017 | 3.84 Billion CNY | 33.14% |
| 2016 | 2.88 Billion CNY | 2.41% |
| 2015 | 2.81 Billion CNY | 13.83% |
| 2014 | 2.47 Billion CNY | 24.97% |
| 2013 | 1.98 Billion CNY | 8.77% |
| 2012 | 1.82 Billion CNY | 30.38% |
| 2011 | 1.39 Billion CNY | 25.99% |
| 2010 | 1.1 Billion CNY | 38.69% |
| 2009 | 799.93 Million CNY | 38.17% |
| 2008 | 578.95 Million CNY | -14.78% |
| 2007 | 679.32 Million CNY | 52.88% |
| 2006 | 444.34 Million CNY | 6.42% |
| 2005 | 417.55 Million CNY | 48.56% |
| 2004 | 281.05 Million CNY | 13.08% |
| 2003 | 248.55 Million CNY | -3.15% |
| 2002 | 256.63 Million CNY | 9.12% |
| 2001 | 235.17 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 804.67 Million CNY | -22.63% |
| 2024 Q1 | 1.03 Billion CNY | 35.23% |
| 2024 Q3 | 748.63 Million CNY | -6.96% |
| 2023 Q3 | 812.77 Million CNY | -15.15% |
| 2023 Q4 | 769.03 Million CNY | -5.38% |
| 2023 Q1 | 1.39 Billion CNY | 76.62% |
| 2023 FY | 3.93 Billion CNY | 10.66% |
| 2023 Q2 | 957.95 Million CNY | -31.45% |
| 2022 Q1 | 1.04 Billion CNY | 13.67% |
| 2022 FY | 3.55 Billion CNY | -10.18% |
| 2022 Q2 | 806.56 Million CNY | -23.17% |
| 2022 Q3 | 910.41 Million CNY | 12.88% |
| 2022 Q4 | 791.2 Million CNY | -13.09% |
| 2021 Q1 | 1.07 Billion CNY | 27.39% |
| 2021 Q3 | 984.58 Million CNY | 0.39% |
| 2021 Q4 | 923.57 Million CNY | -6.2% |
| 2021 FY | 3.96 Billion CNY | 2.45% |
| 2021 Q2 | 980.76 Million CNY | -8.54% |
| 2020 Q4 | 841.79 Million CNY | -4.65% |
| 2020 FY | 3.86 Billion CNY | -23.58% |
| 2020 Q3 | 882.8 Million CNY | -6.37% |
| 2020 Q2 | 942.83 Million CNY | -21.37% |
| 2020 Q1 | 1.19 Billion CNY | 25.3% |
| 2019 Q2 | 1.5 Billion CNY | 16.75% |
| 2019 Q3 | 1.31 Billion CNY | -12.74% |
| 2019 Q1 | 1.28 Billion CNY | 13.58% |
| 2019 FY | 5.05 Billion CNY | -3.33% |
| 2019 Q4 | 956.95 Million CNY | -27.04% |
| 2018 Q2 | 1.37 Billion CNY | 2.82% |
| 2018 FY | 5.23 Billion CNY | 36.11% |
| 2018 Q4 | 1.13 Billion CNY | -17.82% |
| 2018 Q1 | 1.34 Billion CNY | 19.95% |
| 2018 Q3 | 1.37 Billion CNY | 0.01% |
| 2017 FY | 3.84 Billion CNY | 33.14% |
| 2017 Q4 | 1.11 Billion CNY | 1.94% |
| 2017 Q3 | 1.09 Billion CNY | 25.32% |
| 2017 Q2 | 875.34 Million CNY | 16.04% |
| 2017 Q1 | 754.37 Million CNY | 2.86% |
| 2016 Q3 | 711.38 Million CNY | -2.53% |
| 2016 FY | 2.88 Billion CNY | 2.41% |
| 2016 Q4 | 733.4 Million CNY | 3.1% |
| 2016 Q2 | 729.82 Million CNY | 2.32% |
| 2016 Q1 | 713.25 Million CNY | -0.56% |
| 2015 Q2 | 787.81 Million CNY | 26.58% |
| 2015 FY | 2.81 Billion CNY | 13.83% |
| 2015 Q1 | 622.39 Million CNY | -9.9% |
| 2015 Q4 | 717.23 Million CNY | 3.58% |
| 2015 Q3 | 692.42 Million CNY | -12.11% |
| 2014 Q2 | 667.53 Million CNY | 35.59% |
| 2014 Q3 | 626.59 Million CNY | -6.13% |
| 2014 Q4 | 690.75 Million CNY | 10.24% |
| 2014 FY | 2.47 Billion CNY | 24.97% |
| 2014 Q1 | 492.31 Million CNY | -12.23% |
| 2013 Q4 | 560.89 Million CNY | 18.34% |
| 2013 Q2 | 492.48 Million CNY | 8.27% |
| 2013 Q1 | 454.85 Million CNY | -17.62% |
| 2013 FY | 1.98 Billion CNY | 8.77% |
| 2013 Q3 | 473.98 Million CNY | -3.76% |
| 2012 FY | 1.82 Billion CNY | 30.38% |
| 2012 Q1 | 414.68 Million CNY | 7.8% |
| 2012 Q4 | 552.13 Million CNY | 27.06% |
| 2012 Q3 | 434.53 Million CNY | 3.2% |
| 2012 Q2 | 421.05 Million CNY | 1.54% |
| 2011 Q3 | 339.11 Million CNY | 13.16% |
| 2011 Q2 | 299.67 Million CNY | -2.39% |
| 2011 Q1 | 307 Million CNY | -1.65% |
| 2011 FY | 1.39 Billion CNY | 25.99% |
| 2011 Q4 | 384.66 Million CNY | 13.43% |
| 2010 Q2 | 272.22 Million CNY | 4.48% |
| 2010 Q1 | 260.56 Million CNY | -0.2% |
| 2010 FY | 1.1 Billion CNY | 38.69% |
| 2010 Q4 | 312.14 Million CNY | 18.01% |
| 2010 Q3 | 264.49 Million CNY | -2.84% |
| 2009 Q3 | 229.9 Million CNY | 55.15% |
| 2009 Q2 | 148.18 Million CNY | -7.82% |
| 2009 Q1 | 160.75 Million CNY | -1.36% |
| 2009 FY | 799.93 Million CNY | 38.17% |
| 2009 Q4 | 261.09 Million CNY | 13.57% |
| 2008 Q3 | 114.16 Million CNY | -20.14% |
| 2008 Q4 | 162.97 Million CNY | 42.76% |
| 2008 FY | 578.95 Million CNY | -14.78% |
| 2008 Q1 | 158.86 Million CNY | -15.02% |
| 2008 Q2 | 142.94 Million CNY | -10.02% |
| 2007 Q2 | 116.35 Million CNY | 6.4% |
| 2007 Q1 | 109.36 Million CNY | -30.91% |
| 2007 FY | 679.32 Million CNY | 52.88% |
| 2007 Q3 | 157.81 Million CNY | 35.63% |
| 2007 Q4 | 186.93 Million CNY | 18.46% |
| 2006 Q1 | 102.5 Million CNY | -18.6% |
| 2006 Q2 | 69.95 Million CNY | -31.75% |
| 2006 Q3 | 113.59 Million CNY | 62.37% |
| 2006 Q4 | 158.28 Million CNY | 39.35% |
| 2006 FY | 444.34 Million CNY | 6.42% |
| 2005 Q1 | 82.97 Million CNY | 5.81% |
| 2005 Q4 | 125.93 Million CNY | 16.57% |
| 2005 Q3 | 108.03 Million CNY | 7.38% |
| 2005 FY | 417.55 Million CNY | 48.56% |
| 2005 Q2 | 100.6 Million CNY | 21.26% |
| 2004 FY | 281.05 Million CNY | 13.08% |
| 2004 Q1 | 64 Million CNY | 13.46% |
| 2004 Q2 | 60.08 Million CNY | -6.13% |
| 2004 Q3 | 78.55 Million CNY | 30.75% |
| 2004 Q4 | 78.41 Million CNY | -0.17% |
| 2003 Q4 | 56.41 Million CNY | -21.69% |
| 2003 Q3 | 72.03 Million CNY | 0.0% |
| 2003 FY | 248.55 Million CNY | -3.15% |
| 2002 FY | 256.63 Million CNY | 9.12% |
| 2001 FY | 235.17 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 19.29 Billion CNY | 79.801% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 4.59 Billion CNY | 15.26% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.13 Billion CNY | -242.222% |
| Aurora Optoelectronics Co.,Ltd. | -319.56 Million CNY | 1319.558% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 23.41 Million CNY | -16545.862% |
| NanJing Pharmaceutical Company Limited | 3.31 Billion CNY | -17.626% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 936.59 Million CNY | -316.113% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 2.45 Billion CNY | -58.791% |